Enfortumab Vedotin
ATC L01FX13 · 10 markets · 24 records
Enfortumab Vedotin
Forms
AU 5 records · 3 strengths
- 30 mginjectionPADCEVPADCEV enfortumab vedotin 20 mg powder for injection vial
- 20 mginjectionPADCEVPADCEV enfortumab vedotin 20 mg powder for injection vial
Records without a stated strength · 1 PADCEV
US 2 records · 2 strengths
- 30 mg/3 mLinjectionPADCEV EJFV
- 20 mg/2 mLinjectionPADCEV EJFV
GB 2 records · 2 strengths
CA 2 records · 2 strengths
SG 2 records · 2 strengths
- 30 mg/vialinjectionPADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 30MG/VIAL
- 20 mg/vialinjectionPADCEV® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 30MG/VIAL
ES 2 records · 2 strengths
TW 2 records · 2 strengths
- 30 mginjectionPADCEV powder for concentrate for solution for infusion 20 mg備思復凍晶注射劑30毫克
- 20 mginjectionPADCEV powder for concentrate for solution for infusion 20 mg備思復凍晶注射劑20毫克
HK 2 records · 1 strengths
Records without a stated strength · 1 PADCEV powder for concentrate for solution for infusion 20 mg
MX 1 records · 1 strengths
Records without a stated strength · 1 PADCEV
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 PADCEV
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.